Alle Filter zurücksetzen
Kategorien
  • Pharma / Gesundheit
  • Medizintechnik / Medizinprodukte
  • Zahnmedizin (Dental Equipement)
  • Filter zurücksetzen
Regionen/Länder
  • Europa
  • Belgien
  • Bosnien-Herzegowina
  • Bulgarien
  • Dänemark
  • Deutschland
  • Estland
  • Finnland
  • Frankreich
  • Griechenland
  • Irland
  • Italien
  • Kosovo
  • Kroatien
  • Lettland
  • Litauen
  • Mazedonien
  • Moldawien
  • Niederlande
  • Norwegen
  • Österreich
  • Poland
  • Portugal
  • Rumänien
  • Russian Federation
  • Schweden
  • Schweiz
  • Serbien
  • Slowakei
  • Slowenien
  • Spanien
  • Tschechien
  • Türkei
  • Ukraine
  • Ungarn
  • Vatican City State (Holy See)
  • Vereinigtes Königreich
  • Weißrussland
  • Weißrussland
  • Asien / Pazifik
  • Bangladesch
  • China
  • Fiji
  • Hong Kong
  • Indien
  • Indonesien
  • Japan
  • Kasachstan
  • Malaysia
  • Neuseeland
  • North Korea
  • Pakistan
  • Philippinen
  • Singapur
  • Südkorea
  • Taiwan
  • Thailand
  • Usbekistan
  • Vietnam
  • Mittlerer Osten / Afrika
  • Ägypten
  • Algerien
  • Ghana
  • Guinea
  • Iran
  • Israel
  • Katar
  • Kenia
  • Marokko
  • Nigeria
  • Oman
  • Saudi Arabien
  • South Africa
  • Tunesien
  • Vereinigte Arabische Emirate
  • Nordamerika / USA
  • Kanada
  • United States
  • Australien
  • Mittel- / Südamerika
  • Argentinien
  • Bolivien
  • Brasilien
  • Chile
  • Costa Rica
  • Kolumbien
  • Mexiko
  • Peru
  • Uruguay
  • Venezuela
  • Filter zurücksetzen
Herausgeber
  • Datamonitor
  • Euromonitor
  • Finaccord
  • GBI Research
  • Global Markets Direct
  • Global Research & Data Services
  • GlobalData
  • Koncept Analytics
  • Life Science Analytics
  • MarketsandMarkets
  • Technavio
  • Verdict
  • Filter zurücksetzen
Sprache
  • Englisch
  • Filter zurücksetzen
Datum
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • Filter zurücksetzen
laedt
Bestell- und Beratungshotline

Tel.: +49 (0)221 788 748-11
E-Mail: service[at]marktforschung.de

Werbung:

Studie - Dental Plaque – Pipeline Review, H1 2012

Global Markets Direct

Global Markets Direct

5 / 2012
26 Seiten
Typ: Studie
Sprache: Englisch
Regionen: Europa, Asien / Pazifik, Mittlerer Osten / Afrika, Nordamerika / USA, Australien, Mittel- / Südamerika
Verfügbarkeit: verfügbar

Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:

386,70 €*
( 500,00 $)
PDF-Datei per E-Mail, Single User Price , versandkostenfrei
773,40 €*
( 1.000,00 $)
PDF-Datei per E-Mail, Site License Price** , versandkostenfrei
1.160,09 €*
( 1.500,00 $)
PDF-Datei per E-Mail, Enterprisewide Price (Global Site License)*** , versandkostenfrei


Dental Plaque — Pipeline Review, H1 2012


Summary


Global Markets Direct’s, 'Dental Plaque - Pipeline Review, H1 2012', provides an overview of the Dental Plaque therapeutic pipeline. This report provides information on the therapeutic development for Dental Plaque, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dental Plaque. 'Dental Plaque - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Scope

- A snapshot of the global therapeutic scenario for Dental Plaque.
- A review of the Dental Plaque products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Dental Plaque pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.


Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Dental Plaque.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Dental Plaque pipeline depth and focus of Dental Plaque therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Introduction 4

Global Markets Direct Report Coverage 4

Dental Plaque Overview 5

Therapeutics Development 6

An Overview of Pipeline Products for Dental Plaque 6

Dental Plaque Therapeutics under Development by Companies 8

Dental Plaque Therapeutics under Investigation by Universities/Institutes 9

Mid Clinical Stage Products 10

Comparative Analysis 10

Early Clinical Stage Products 11

Comparative Analysis 11

Pre-Clinical Stage Products 12

Comparative Analysis 12

Dental Plaque Therapeutics — Products under Development by Companies 13

Dental Plaque Therapeutics — Products under Investigation by Universities/Institutes 14

Companies Involved in Dental Plaque Therapeutics Development 15

Aphios Corporation 15

Dental Plaque — Therapeutics Assessment 16

Assessment by Monotherapy Products 16

Assessment by Route of Administration 17

Assessment by Molecule Type 19

Drug Profiles 21

Asterias - Drug Profile 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

Chlorhexidine Digluconate - Drug Profile 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

Green Propolis - Drug Profile 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

Dental Plaque Therapeutics - Dormant Products 24

Appendix 25

Methodology 25

Coverage 25

Secondary Research 25

Primary Research 25

Expert Panel Validation 25

Contact Us 26

Disclaimer 26





List of Tables

Number of Products Under Development for Dental Plaque, H1 2012 6

Products under Development for Dental Plaque — Comparative Analysis, H1 2012 7

Number of Products under Development by Companies, H1 2012 8

Number of Products under Investigation by Universities/Institutes, H1 2012 9

Comparative Analysis by Mid Clinical Stage Development, H1 2012 10

Comparative Analysis by Early Clinical Stage Development, H1 2012 11

Comparative Analysis by Pre-Clinical Stage Development, H1 2012 12

Products under Development by Companies, H1 2012 13

Products under Investigation by Universities/Institutes, H1 2012 14

Aphios Corporation, H1 2012 15

Assessment by Monotherapy Products, H1 2012 16

Assessment by Stage and Route of Administration, H1 2012 18

Assessment by Stage and Molecule Type, H1 2012 20

Dental Plaque Therapeutics — Dormant Products 24





List of Figures

Number of Products under Development for Dental Plaque, H1 2012 6

Products under Development for Dental Plaque — Comparative Analysis, H1 2012 7

Products under Development by Companies, H1 2012 8

Products under Investigation by Universities/Institutes, H1 2012 9

Mid Clinical Stage Products, H1 2012 10

Early Clinical Stage Products, H1 2012 11

Pre-Clinical Stage Products, H1 2012 12

Assessment by Monotherapy Products, H1 2012 16

Assessment by Route of Administration, H1 2012 17

Assessment by Stage and Route of Administration, H1 2012 18

Assessment by Molecule Type, H1 2012 19

Assessment by Stage and Molecule Type, H1 2012 20

*Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.

Hinweise: **The report can be shared by users within one office (one geographical location) ***Across Geographical locations (by the purchasing company only)

Für Sie protokollierte Studien / Marktanalysen:
  zuletzt angesehene Studien: